We recently published a list of Jim Cramer Discusses These 11 Stocks & President Trump’s Approval Drop. In this article, we ...

Mexico, China and Canada were the largest importers for the US in 2023, and the first targets of US President Donald Trump’s ...

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...

After steel and aluminium, US President Donald Trump has set his sights on slapping 25 percent tariffs on semiconductors, ...

Novo Nordisk alleges Singaporean biotech KBP Biosciences made misleading statements before the two firms inked a licensing ...

The trade threats could reduce exports to the United States and dampen investment in Europe, dealing a blow to growth at a ...

Over $600 billion in European goods were imported by the U.S. last year. New tariffs from President Trump will likely hit ...

The potential market for the drugs is massive — more than 40 percent of adults in the U.S. are obese — and has seen explosive growth. The number of Americans taking GLP-1s for weight loss rose more ...

However, while American car manufacturers are dependent on Mexico, Cramer pointed out that Japanese and ... He favors the ...

If Denmark ordered Novo Nordisk to stop supplying the U.S., the ... Just days ago, Trump announced a one-month pause on tariffs against Mexico and Canada after last-minute talks.

Shares of Novo Nordisk (NYSE: NVO) were moving higher on Wednesday. The company's stock gained 4.9% as of 1:50 p.m. ET, but gained as much as 5.8% earlier in the day. The leg up comes as the S&P ...

The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower growth this year.